Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18523534 | 0.76 | RIPK1 (0.32) | — | |
| SCHEMBL17559963 | 0.74 | — | — | |
| SCHEMBL8933622 | 0.71 | TSHR (0.35) | LMNA | |
| SCHEMBL17529803 | 0.69 | GAA (0.33) | — | |
| SCHEMBL9242665 | 0.67 | — | — | |
| SCHEMBL6226452 | 0.67 | TAAR1 (0.38) | KMT2A | |
| SCHEMBL18397 | 0.67 | MAPK1 (0.36) | MEN1KMT2ALMNACYP2D6 | |
| SCHEMBL28898247 | 0.66 | — | — | |
| Hydrochloric Acid SCHEMBL22288246 | 0.65 | MAPK1 (0.35) | MEN1KMT2ALMNACYP2D6 | |
| SCHEMBL1618736 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115232177-A | Chemical synthesis method of shigella dysenteriae type 10O-antigen oligosaccharide | 江南大学 | 2022-10-25 | — | — | CN | claimed |
| US-20170349520-A1 | SINGLY PROTECTED 2,2' -DIHYDROXYBIARYLS | EVONIK DEGUSSA GMBH (DE) | 2017-12-07 | — | — | US | claimed |
| US-8969546-B2 | Compounds useful in imaging and therapy | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) | 2015-03-03 | — | — | US | claimed |
| US-20130211066-A1 | COMPOUNDS USEFUL IN IMAGING AND THERAPY | ALBERTA HEALTH SERVICES (CA) | 2013-08-15 | — | — | US | claimed |
| CN-115568282-A | Use of anti-aging glycopeptides to treat dry eye, retinal degenerative diseases, or ocular inflammation | 普罗托基尼蒂克有限公司 | 2023-01-03 | — | — | CN | disclosed |
| CN-114787139-A | Processes and intermediates for preparing MCL1 inhibitors | 吉利德科学公司 | 2022-07-22 | — | — | CN | disclosed |
| US-20170349520-A1 | SINGLY PROTECTED 2,2' -DIHYDROXYBIARYLS | EVONIK DEGUSSA GMBH (DE) | 2017-12-07 | — | — | US | disclosed |
| EP-3189176-A1 | ONE-SIDED PROTECTED 2,2 -DIHYDROXY BIARYLS AND ELECTROCHEMICAL METHOD FOR THE PRODUCTION THEREOF | Evonik Degussa GmbH (DE) | 2017-07-12 | — | — | EP | disclosed |
| WO-2016034326-A1 | ONE-SIDED PROTECTED 2,2 -DIHYDROXY BIARYLS AND ELECTROCHEMICAL METHOD FOR THE PRODUCTION THEREOF | EVONIK DEGUSSA GMBH (DE) | 2016-03-10 | — | — | WO | disclosed |
| US-20160002275-A1 | PROCESS FOR PREPARATION AND PURIFICATION OF CANAGLIFLOZIN | CADILA HEALTHCARE LIMITED (IN) | 2016-01-07 | — | — | US | disclosed |
| US-8969546-B2 | Compounds useful in imaging and therapy | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) | 2015-03-03 | — | — | US | disclosed |
| US-20130211066-A1 | COMPOUNDS USEFUL IN IMAGING AND THERAPY | ALBERTA HEALTH SERVICES (CA) | 2013-08-15 | — | — | US | disclosed |
| WO-2011160216-A2 | COMPOUNDS USEFUL IN IMAGING AND THERAPY | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) | 2011-12-29 | — | — | WO | disclosed |
| US-20090294369-A1 | Selective Fixing Agents for Halogenated Aromatic Compounds Contained in Media and Method for Selective Fixing | OSAKA UNIVERSITY (JP) | 2009-12-03 | — | — | US | disclosed |
| EP-2067801-A1 | Synthesis of Hybrid Block Copolymers | Intezyne Technologies Incorporated (US) | 2009-06-10 | — | — | EP | disclosed |
| EP-2017317-A1 | SELECTIVE STICKING AGENTS FOR HALOGENATED AROMATIC COMPOUNDS CONTAINED IN MEDIA AND METHOD FOR SELECTIVE STICKING | Neos Co., Ltd. (JP) | 2009-01-21 | — | — | EP | disclosed |
| EP-2001885-A2 | OCTAHYDRO-PYRROLO[3,4-B]PYRROLE DERIVATIVES | Abbott Laboratories (US) | 2008-12-17 | — | — | EP | disclosed |
| WO-2007100990-A2 | OCTAHYDRO-PYRROLO[3,4-B] PYRROLE DERIVATIVES AND THEIR USE AS HISTAMINE-3 RECEPTOR LIGANDS | ABBOTT LABORATORIES (US) | 2007-09-07 | — | — | WO | disclosed |
| US-20040038943-A1 | Indole and benzimidazole 15-lipoxygenase inhibitors | CONNOR DAVID THOMAS (US) | 2004-02-26 | — | — | US | disclosed |
| US-6162808-A | Compounds | ASTRAZENECA U.K. LIMITED (GB) | 2000-12-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040038943-A1 | Indole and benzimidazole 15-lipoxygenase inhibitors | ALOX15, ALOX5, ALOX12 | MEN1 4793/4885KMT2A 2042/4885LMNA 1070/4885 |
| US-20130211066-A1 | COMPOUNDS USEFUL IN IMAGING AND THERAPY | PAICS, MPI, ALDOA | MEN1 1006/4885KMT2A 1008/4885LMNA 2442/4885 |
| US-20160002275-A1 | PROCESS FOR PREPARATION AND PURIFICATION OF CANAGLIFLOZIN | SLC5A2, SLC5A1, SLC2A4 | MEN1 3555/4885KMT2A 3878/4885LMNA 3826/4885 |
| US-20170349520-A1 | SINGLY PROTECTED 2,2' -DIHYDROXYBIARYLS | DBH, COMT, DRD2 | MEN1 1920/4885KMT2A 2303/4885LMNA 2314/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.